Earnings beat, analyst upgrades and near-term estimate volatility
Key Questions
What were Enphase Energy's key Q4 financial results?
Enphase reported Q4 revenue of $343.3M, beating expectations despite a 10.3% year-over-year decline. Free cash flow was $38M, down 76%, with $1.51B in cash on hand. Europe revenue fell 29% quarter-over-quarter.
Did Enphase Energy recently monetize tax credits?
Yes, on March 31, Enphase sold $235M in production tax credits (PTCs) for $218.55M cash, as disclosed in an 8-K filing. This transaction is expected to reduce Q1 GAAP gross margins by 6.7 percentage points.
When is Enphase Energy's Q1 2026 earnings call?
The Q1 2026 conference call is scheduled for April 28 at 4:30 ET. Consensus estimates are $0.30 EPS and $283M revenue, down from prior $0.43.
Why did Enphase Energy's stock price recently decline?
The stock fell 6.93% to a low of $31.30 due to market concerns over the Q1 GAAP gross margin hit from the PTC sale. It dropped an additional 7% following the April 28 Q1 call announcement.
What are the current analyst price targets for ENPH?
Northland Securities maintains a Buy rating with a $62 price target. The average PT ranges from $37-$62, with $41.72 Hold and $38 average; Zacks ranks it #3 Hold with a discounted P/E of 15.68.
How has Enphase Energy's stock performed year-to-date?
ENPH is up 4.96% YTD with a market cap of $4.41B. It experienced an earlier +18-19% rally and ranks #2 in volatility compared to peers like SEDG.
What legal issues are surrounding Enphase Energy?
There are class action lawsuits alleging inadequate risk warnings, with reminders from firms like Portnoy and Pomerantz. Legal noise contributes to stock dips alongside tariffs, competition, and cash burn concerns.
What challenges is Enphase facing in key markets?
Europe revenue declined 29% QoQ, and China VAT hikes are increasing costs. The company leads in microinverters but faces institutional exits (-31%), insurer net sells of $3.96M, and competition.
Q4 $343.3M beat (-10.3%)/FCF $38M (-76%)/$1.51B cash/Europe -29% QoQ; reconf $235M 45X PTC sale Mar31 $218.55M cash (8-K, Q1 GAAP GM -6.7pp hit spooks mkt -6.93%/$31.29-31.30 low/-7% on Apr28 Q1 call annc, non-GAAP ex'd, YTD +4.96% mcap $4.41B); Q1 4/28 4:30ET call conf est $0.30/$283M (down $0.43, Zacks #3 Hold/P/E 15.68 disc), 1y PT 45.89 fits $37-62 range (Northland Buy $62); China VAT hikes costs; dupes legal noise (Portnoy/Pomerantz reminders); dips on tariffs/comp/burn/legal; DEF14A $1.5B'25/46.6-48.2%GM/85%pay/5-13-26 AGM; +18-19%YTD rally (ENPH #2 vol)/AU/NZ vs SEDG; inst exit/-31%; ins net sell $3.96M; microinv lead; PT $43-62/$41.72 Hold/$38 avg/$37 Hold; ETFs 258 inc TAN/ISUN. Q4 transcript recaps confirm beat/guide; recent quote conf $31.29 low persistence.